H.C. Wainwright Starts Bionano Genomics (BNGO) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq set for sharp drop as Amazon, Intel amplify AI spending worries
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
Tweet
Share
E-mailGet Alerts BNGO Hot Sheet
Price: $1.18 -1.67%
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 43 | New: 7
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 43 | New: 7
Join SI Premium – FREE
H.C. Wainwright analyst Yi Chen initiates coverage on Bionano Genomics (NASDAQ: BNGO) with a Buy rating and a price target of $10.00.
For an analyst ratings summary and ratings history on Bionano Genomics click here. For more ratings news on Bionano Genomics click here.
Shares of Bionano Genomics closed at $2.83 yesterday.
You May Also Be Interested In
- Erste Group Starts Nasdaq OMX Group Inc. (NDAQ) at Buy
- Goldman Sachs Upgrades Chow Tai Fook Jewellery Group Ltd. (1929:HK) (CJEWF) to Buy
- Seaport Global Securities Starts Anthropic (ANT), Defers Offering Rating
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
